Compumedics Limited (ASX:CMP) Annual Report 2025



The latest annual report of Compumedics Limited (CMP) was published on 30 Jun 2025. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - CMP Annual Results

Amounts in AUD

Total Revenue
$50.96M
Gross Profit
$28.13M
EBIT
$2.11M
Net Tangible Assets
$22.57M
Net Income
$-1.27M
Capital Expenditures
-

CMP Income Statement 2025 Annual Report

As per the latest Income Statement of CMP, the Net revenue increased by - (-) compared to the previous period. The operating income in 2025 increased by - (-). The net income as per the annual report was $-1.27M which decreased by $-773.00K (-155%) compared to previous year.

Income Statement Report (2025/2024)

2025 2024
Total Revenue $50.96M $0.00
Gross Profit $28.13M $28.13M
Operating Income - -
Income Before Tax - -
Net Income $-1.27M $-499.00K

Balance Sheet - CMP 2025 Annual Report

Read further: CMP Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Compumedics Limited showed the company increased the cash on balance sheet by $0.00 (0%). The Net tangible assets of CMP on the balance sheet were at $22.57M which is $0.00 (0%) more than previous annual report. The total stockholder equity also increased by - (-) compared to previous reporting period.

Balance Sheet Statement Report (2025/2024)

2025 2024
Cash $2.69M $2.69M
Total Assets - -
Long Term Debt - -
Total Liabilities $13.88M $13.88M
Total Shareholder Equity - -
Net Tangible Assets $22.57M $22.57M

Cash Flow Statement - CMP 2025 Annual Report

The 2025 annual cash flow statement of Compumedics Limited showed that the net income decreased by $-773.00K (-155%) compared to previous reporting period. Also the capital expenditure of CMP increased by - (-).

As of 2025, the total cash from investing activities was - and total cash from financing activities was -.

Cash Flow Statement Report (2025/2024)

2025 2024
Net Income $-1.27M $-499.00K
Capital Expenditures - -
Dividends Paid - -
Total Cash From From Investing Activities - -
Total Cash From From Financing Activities - -

Compumedics Limited Annual Report History

Income Statement

Income Statement history of Compumedics Limited (ASX:CMP)

30 Jun 2025 30 Jun 2024 30 Jun 2022 30 Jun 2021
Total Revenue $50.96M $0.00 $0.00 $35.74M
Cost Of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Research Development - - - -
Selling General Administrative - - - -
Non Recurring - - - -
Other Operating Expenses - - - -
Total Operating Expenses $0.00 $0.00 $0.00 $0.00
Operating Income - - - -
Total Other Income Expense Net - - - -
Ebit $0.00 $0.00 $0.00 $0.00
Interest Expense - - - -
Income Before Tax - - - -
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Minority Interest - - - -
Net Income From Continuing Ops - - - -
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income $-1.27M $-499.00K $0.00 $998.00K
Net Income Applicable To Common Shares - - - -

Balance Sheet Statement

Balance Sheet Statement history of Compumedics Limited (ASX:CMP)

30 Jun 2025 30 Jun 2024 30 Jun 2022 30 Jun 2021
Cash $2.69M $2.69M - -
Total Assets - - - -
Total Liab $13.88M $13.88M - -
Long Term Debt - - - -
Total Stockholder Equity - - - -
Net Tangible Assets $22.57M $22.57M - -

Cash Flow Statement

Cash Flow Statement history of Compumedics Limited (ASX:CMP)

30 Jun 2025 30 Jun 2024 30 Jun 2022 30 Jun 2021
Net Income $-1.27M $-499.00K - -
Capital Expenditures - - - -
Dividends Paid - - - -
Total Cashflows From Investing Activities - - - -
Total Cash From Financing Activities - - - -